名称未設定-1
|
|
|
- ひろと やたけ
- 7 years ago
- Views:
Transcription
1 2013 Expanding Leading-edge Innovations
2 ,4770.8% % %
3 1
4 > > > % 2
5 > > > 50.0% % > > BBI > 3 3
6 LD/HD24 ARB HD 10mg BBI BBI CEO R&D EMA P.8
7 0.8%3, % %100 4,000 3,000 3,795 3,504 3,477 2,963 2,640 1,600 1, ,302 1, , ,000 1, ,000 8,000 4, , , , , , , ,488 7, ,296 4, EBITDAEarnings Before Interest, Taxes, Depreciation and Amortization 2ROE 3ROA 5
8 Expanding Leading-edge dge Innovations dg
9 Contents BBI608BBI CSR ISO ISO
10 : 8
11 9 Q.1 BBI 2
12 Q MR MR MR MR2013 Q.3 BBI608BBI503 BBI WT WT1 BBI608BBI503 10
13 Q.4 BBI CNS CNS MRe- 11
14 Q.5 POCProof of Concept BBI BBICEOR&D PC iPS Global Oncology LGLead GenerationLOLead Optimization 12
15 Q Q.7 CSR21 2QOL 2 Q.8 13
16 BBI
17 20134 LG 1 LO 2 1 LGLead Generation 2 LOLead Optimization BBI BBICEO CSOChief Scientific OfficerR&D GBSCGlobal Business Strategy Committee GRDC Global R&D Committee GCD Global Clinical Development Head of GCD Head of GCD Global Oncology 15
18 POC POC SB623 BBI BBI608BBI503 WT2725 POCProof of Concept POC NDDC DSKiPS ips ips
19 inips BBI COPDSUN ips ips EPI-743EPI-589 CEO mg FDA 17
20 20129 EMA DSP-2230 Nav1.7Nav ADHDSEP SEP TBial FDA 11 / SB623 / BBI2 BBI608BBI503 BBI BBI / Top Ten Promising Late Stage Cancer Drugs Fierce Biotech BBI WT4869WT2725 WT1 18
21 WT1T CTLWT1 CTL WT4869 MDS/ DSP-3025 Toll-like receptor 7TLR7 AstraZeneca AstraZeneca4 WT COPDSUN-101 DSP-3025 SUN g20131 IBSDSP- 6952Intercept NASHDSP-1747 DSP-1747 PBC DSP-1747 InterceptINT-747 FXR Farnesoid Xreceptor NASH Intercept PBCNASH / NASH SUN-101glycopyrrolate eflow SUN-101 LAMA COPD 19
22 20
23 21
24 22 4 GMP FDA EMATGA GMP ICH EU RABS 4 GMP
25 マーケティング 国内医薬品市場では 成長品目へのリソース集中による売上の拡大 北米市場では ラツーダ の製品価値最大化に 注力しています 基本方針 北米事業では ラツーダ の利益最大化を最優先しつ 当社では 第三期中期経営計画の基本方針として 強 つ サノビオン ファーマシューティカルズ インク 以下 サ 固な国内収益基盤の確立 海外事業の収益最大化とさ ノビオン社 の既存製品販売体制の最適化をはじめとし らなる事業拡大 などを掲げています た経営効率のさらなる向上を推進しています 国内医薬品事業では 成長品目での売上拡大に向け 中国事業では メペム メロペン をはじめとした既 戦略品である アイミクス アバプロ ロナセン トレ 存製品の販売拡大および新製品の投入により 事業規模 リーフ や 新製品である メトグルコ シュアポスト パ と収益の最大化を図っています キシルCR などへ 営業資源を集中しています エリア別マーケティング体制 2013 年 3 月 31 日現在 中国 MR 数 米国 MR 数 3,072億円 経営効率化のさらなる推進 日本 MR 数 1,410 名 医薬品事業 売上高目標 地域別 3,101億円 ラツーダ の利益最大化 350 名 既存製品の利益拡大 新製品の投入 830 名 成長品目へのリソース集中 3,256 億円 海外その他 中国 北米 日本 年度 予想 MR 医薬情報担当者 アニュアルレポート
26 1,745 MR 1, ,000 1,500 1, ,799 1,745 1, CNS
27 25 MR e CR CR SSRI % % ACE ARB 24 ARB AVAPRO APROVEL
28 ARB % % CR SSRI SU 2 A1c
29 %112.3% 468.7% %142 B B Gene Activation technology CTH
30 1,158 MR % 134.5% ,500 1, ,084 1,158 1, CM 20141Q % %6.4% MR MR 28
31 20128 Inhalation Solution COPD % 25.3% SUN-101COPD MR HFA COPD 29
32 MR MR % E / 30
33 DSP DS DS POCTPoint of Care TestingCa ESiPS Companion Diagnostics SS POCT 31
34 CSR CSR CSR ISO26000 ISO CSR 32
35 ISO26000 ISO26000 P P.34, 35, 4 P P P.40 3 P.35, 40. P.34, 35, P.39 P.34, 39 P.41 33
36 Good Clinical Practice:GCP 2012DVD 34
37 % OJTOn-the-Job Training OffJTOff-the-Job Training OJTOffJT 38% 19% 19% 9% 9% 6%
38 OUTPUT OUTPUT O INPUT
39 PRTR % CO CO CO % 108% CO2 CO % % 1% % %
40 CO2 CO CO % CO2 CO2 3R ,314t 21% 7,628t 21% 14.9t18% 0.1%1% 1% % CO ,000 10,000 8,000 6,000 4,000 2,
41 TDnet ISO
42 ,000 DI-SaGaS FAQ QA MR MR MR MR Shink MR ShinkShink SafetyThink MR e- MR MR MR Shink , % 19.6% 19.0% 11.1% 8.3% 8.6% 2.7% 40
43 20125 NPO MNMJ TABLE FOR TWO TABLE FOR TWO 120 TABLE FOR TWO International 1 41
44 SUKOYAKA SUKOYAKA ,800 42
45 50.22%
46 GCC 44
47 2012 BCP IT Act Plan Do Check 45
48 IR
49 URL:
50 DSP& Vice Chair, Executive Vice President and Chief Financial Officer Executive Vice President Head of Global Clinical Development for DSP Group IT Executive Vice President and Chief Medical Officer Antony Loebel BBI President, Chief Executive Officer and Chief Medical Officer Head of Global Oncology for DSP Group Chiang J. Li 48
51 Contents
52 , , , , , , , ,226 53,015 22, % 37.2% 40.1% 17.9% 8.4% 101,686 98, , , , , , , , ,130 25,044 20,402 30,952 35,625 31,166 18,158 16,328 25,050 31,423 32,168 10,044 8,630 16,796 20,958 19,988 37,174 2,396 (12,066) 27, , , , , ,540 69,862 66,697 69,794 74,084 69, , , , , , , , , ,000 53, , , ,681 18,260 13, , , , , ,496 59,844 56,891 68,160 51,371 52,819 12,384 8,742 8,663 6,471 10,569 35,085 40,232 44,628 18,650 11,455 60,333 59,880 77,971 56,448 41, % 5.8% 8.2% 12.0% 11.8% 3.0% 2.7% 5.0% 6.3% 6.2% 1.7% 1.5% 2.8% 4.1% 5.1% 57.5% 57.1% 54.9% 54.8% 82.9% 50
53 263, , , , , ,554 (0.8%) $3,699,191 24,521 22,032 9,696 3,820 3,630 3, % 1,416, % 8.4% 3.9% 2.2% 2.1% 2.3% 99,385 99, , , , , % 1,081, , ,312 86,461 52,404 51,546 51,240 (4.4%) 2,351,000 39,814 45,555 28,886 11,585 10,113 13, % 266,426 41,457 38,415 25,687 11,686 13,836 12, % 193,170 25,592 22,605 15,377 6,924 7,968 6, % 106,851 1,451.5% 395, , , , , , ,241 (0.2%) 3,547,223 70,280 65,241 68,336 32,611 34,473 35, % 743, , , , , , , % 6,459,777 67,915 56,039 80,071 49,196 45,927 60, % 1,327,990 13,598 20,484 24,262 16,802 16,258 9,248 (0.8%) 1,416, , , , , , , % 3,715,404 47,266 40,870 29,636 17,444 15,929 15, % 636,638 15,491 9,543 6,616 3,064 4,294 6, % 131,745 11,870 12,008 8,901 5,233 5,821 5,316 (12.8%) 373,245 48,802 54,875 36,179 16,446 16,040 18, % 641, % $ % % % 17.4% 11.8% 6.6% 5.9% 7.7% 8.2% 7.6% 7.3% 5.2% 6.5% 5.5% 6.5% 5.8% 5.2% 3.5% 4.2% 3.4% 79.6% 79.8% 73.2% 66.8% 67.1% 61.9% 51
54 BBI 9 9 SRD % %3, , ,460 2,000 1, ,000 3,000 2,640 2, , , ,
55 , % 1, % 50% 33% 2 3% 12%
56 1, % %1, % % % % % % % % %
57 ,500 5,000 6,267 5,899 6,072 5,594 3, ,072 BBISRD 83,334 BBISRD 455 2,039 BBI 1782, , % 2, , ,000 2,000 1, , ,435 3,492 3,240 3,
58 BBISRD ,500 1, ,000-1,500-2, (213) (118) 1,319 (1,518) (66) (44) (203) (202) (329) (550) % 82.9% 54.8% 54.9% 57.1% 57.5% 90.6% 83.1% 54.3% 52.2% 62.3% 114.8% 17.5% 8.5% 431.2% 218.4% 205.4% 195.9%
59 EBITDA ,690 3, % % % ,
60 58
61 59
62 ,753 12,953 $ 199,500 86,463 99, ,819 2,897 2,971 30,819 95,093 99,653 1,011,628 34,574 25, ,808 (105) (110) (1,117) 132, ,564 1,409,138 62,689 58, ,904 30,098 31, ,191 2,977 4,715 31, , ,251 3,547,223 10,277 10, ,330 92,586 91, , , ,959 1,120,777 5,799 2,121 61, , ,444 2,276,755 (144,153) (141,747) (1,533,542) 69,862 66, , ,426 40,059 29, ,160 71,294 64, ,447 50,664 5, ,979 24,352 37, ,064 7,570 11,625 80,532 8,999 9,075 95, , ,462 2,169, , ,410 $ 6,459,777 60
63 20,000 10,000 $ 212, ,518 2,118 46,812 2,115 44,404 11, , ,488 2,280 44,919 5,437 40,163 5, ,966 1, ,596 22, ,000 22, , ,340 1,327,989 95,000 11,030 27, , ,000 10,790 5, ,217 1,010, , ,406 1,416,384 22,400 22, ,298 15, ,557 (651) 15, ,664 (649) 168,723 3,282,522 (6,926) 346, ,275 3,682,617 14,121 (11,039) 3, , ,219 8,016 (32,064) (24,048) 319, , ,223 (117,436) 32,787 3,715,404 $6,459,777 61
64 , , , ,994 25,044 1,091 (1,072) (417) (4,841) (1,090) (557) (6,886) 18,158 6,788 1,326 8,114 10, ,044 6,105 21,025 27,130 37,174 37, ,396 98, , ,137 20,402 1,025 (1,123) (2,338) (224) 1,241 (1,224) (1,431) (4,074) 16,328 12,291 (4,593) 7,698 8, ,630 2,602 (8,836) (6,234) 2,396 2,396 $3,699,191 1,081,765 2,617,426 2,351, ,426 11,606 (11,404) (4,436) (51,500) (11,596) (5,926) (73,256) 193,170 72,213 14,106 86,319 $ 106,851 $ $ 106,851 64, , , , ,468 62
65 ,900 (587) 22,400 15, ,186 (649) 341,797 5,414 (23,228) (17,814) 323,983 (7,152) (7,152) (7,152) 8,630 8,630 8,630 (2) (0) (0) (0) 0 (0) ,602 (8,836) (6,234) (6,234) 397,900 (589) 22,400 15, ,664 (649) 343,275 8,016 (32,064) (24,048) 319,227 (7,151) (7,151) (7,151) 10,044 10,044 10,044 (1) (2) (2) (2) (0) 6,105 21,025 27,130 27, ,900 (590) 22,400 15, ,557 (651) 346,166 14,121 (11,039) 3, ,248 $238,298 $168,723 $3,251,745 $(6,904) $3,651,862 $ 85,276 $(341,106) $(255,830) $3,396,032 (76,074) (76,074) (76,074) 106, , ,851 (22) (22) (22) (0) , , , ,617 $238,298 $168,723 $3,282,522 $(6,926) $3,682,617 $150,223 $(117,436) $ 32,787 $3,715,404 63
66 ,158 31, ,773 (228) (1,091) 1,072 4,841 6,806 (3,732) (4,877) 6,837 63,288 1,442 (1,074) (3,627) (10,115) 49,914 (5,179) (7,818) (2,209) 18 (4,926) 3 (2,344) 265 (24,852) (7,981) 3 (55,020) (13,000) (2) (7,151) (68) (20,221) 4,582 (20,745) 92,179 71,434 16,328 36,468 2,338 3,764 (130) (1,025) 1, ,224 5,824 (2,585) (2,490) 1,570 62,633 1,349 (1,106) (14,493) 48,383 (6,715) (2,136) 1,945 5, (3,203) 47 (22) (4,373) (50,000) 19,895 15,000 (10,600) (1) (7,149) (68) (32,923) (1,776) 9,311 82,868 92,179 $ 193, ,106 4,436 40,138 (2,426) (11,606) 11,404 51,500 72,404 (39,702) (51,883) 72, ,277 15,340 (11,426) (38,585) (107,606) 531,000 (55,096) (83,170) (23,500) 191 (52,404) 32 (24,936) 2,819 (264,383) (84,904) 32 (585,319) (138,298) (21) (76,074) (725) (215,118) 48,745 (220,692) 980,628 $ 759,936 64
67 TEL FAX TEL FAX ,1294, ,900, , SMBC UFJ DSP& DS DS 199, , , , , , , , , BNY GCM CLIENT ACCOUNT JPRD AC ISG FE-AC 3, % 10.05% 1.71% 19.33% 0.15% 60.01% 2, , ,000 1,500 80,000 1,000 60,000 40, ,
68 TEL FAX TEL FAX
名称未設定-1
Contents 11 5 52 6 62 63 64 49 11 213212 3 347,724 35,396 379,513 296,262 264,37 133,125 13,243 152,226 53,15 22,51 38.3% 37.2% 4.1% 17.9% 8.4% 11,686 98,857 11,3 112,263 13,741 22,994 231,137 238,531
untitled
2 6 26 http://www.nitto.co.jp/ 2 3 5 7 9 12 13 15 17 19 21 22 23 24 25 26 27 28 29 3 31 33 34 35 37 41 42 http://www.nitto.co.jp 1 2 3 4 http://www.nitto.co.jp/ 2,712 386 6,263 475 2,514 3,274 6,263 52
Kumagai09-hi-2.indd
CSR2009 CONTENTS 1 2 3 4 5 6 7 8 9 10 350 11 12 13 14 15 16 17 18 Do Check Action Plan 19 20 INPUT r r r r k k OUTPUT 21 22 Plan Action Check Do 23 24 25 26 27 28 16:50 7:30 8:00 8:30 9:30 10:00 18:00
untitled
Change and Innovation 214 213 1 215 3 Change and Innovation 3 resilience 2 13 23 43 67 Overview 2 4 6 8 1 12 213 1 213 215 Management Strategy 14 16 Our Operations 24 26 28 3 32 34 36 4 42 CSR & Governance
.......p...{..P01-48(TF)
1 2 3 5 6 7 8 9 10 Act Plan Check Act Do Plan Check Do 11 12 13 14 INPUT OUTPUT 16 17 18 19 20 21 22 23 24 25 26 27 30 33 32 33 34 35 36 37 36 37 38 33 40 41 42 43 44 45 46 47 48 49 50 51 1. 2. 3.
Contents P. P. 1
Contents P. P. 1 P. 2 TOP MESSAGE 3 4 P. P. 5 P. 6 7 8 9 P. P. P. P. P. 10 11 12 Economy P. P. 13 14 Economy P. 1,078 1,000 966 888 800 787 716 672 600 574 546 556 500 417 373 449 470 400 315 336 218 223
技術流出防止指針公表用.PDF
15 3 1 4 .. 2 2.. 4. 6.10 10.14.16.19.24.26.28 1 2 1 2002 7 3 2002 3 4 2 3 5 4 4 6 7 8 5 5 9 plan (do) (check) (act) 1) 2) 3) 4) 5) 6) 7) 10 11 12 13 14 15 16 17 18 6 6 19 / / 20 21 22 7 23 8 24 25 26
1 2 3 1 2 3
2007 1 2 3 1 2 3 1 CONTENTS HP 2 3 3,303 323 150 479 2,350 521 335 1,492 4 5 1 6 7 2 8 1990 47 2006 9 10 3 11 12 ap1621 ap2627 ap2225 ap3035 ap3655 ap2829 13 14 15 3 1 3 2 1 5 4 1 4 2 2 3 4 HP 16 17 18
,889 99, , , ,031 8,952 13,261 16,443 14,464 17,948 % ,037 8,848 10,927
2013 2013 3 3 313 31 2008 2009 2010 2011 2012 90,889 99,764 104,069 103,232 107,031 8,952 13,261 16,443 14,464 17,948 % 9.8 13.3 15.8 14.0 16.8 2,037 8,848 10,927 9,231 12,422 % 2.2 8.9 10.5 8.9 11.6 4,575
AppleiPad TPP ,600 2 Q OverDrive 1 5 MD Viewer 1 md-dc IT 20 1 MD Viewer Q OverDrive 90% Kodansha Advanc
MEDIA DO Co.,Ltd. 1996 4 1 1999 4 1 8 8,543 9,750 126 9630 17 2015 3 1 2015 8 31 151-0053 30 3MIDWEST5F 460-0002 5 10 9F 771-6403 5-23 U R L http://www.mediado.jp ir@mediado.jp 03-5358-7787 www.mediado.jp
KAITEKIレポート
INDEX R e p o r t Corporate Social Responsibility 1 2 2011 3 11 MCHC 616 26 6 MCHCGood Chemistry for Tomorrow APTSIS 10 20253 Sustainability Health Comfort 3 MBA Master of Business Administration MOT Management
01
01 02 03 04 KOKUYO GROUP CSR REPORT 2009 KOKUYO GROUP CSR REPORT 2009 CONTENTS 9 11 12 13 15 17 18 19 20 5 05 06 07 08 09 a 2 5 1 4 3 2 3 4 5 1 10 11 12 13 14 15 16 17 a 18 19 a 20 21 KOKUYO GROUP CSR
col_ARJ_CV0303入稿.indd
COLOPL 2015 2014.10.1 2015.9.30 About COLOPL Entertainment in Real Life VR VR PC VR 2003 Internet Personal Computer 1 8 Unity 2 3 Web 2013 VR 2016 VR 2011 2008 Virtual Reality VR Smartphone Feature Phone
P001-052.indd
Quality of Life 1 TEIJIN CSR Report 2014 2 TEIJIN CSR Report 2014 CONTENTS 3 5 9 15 21 23 25 26 28 37 38 41 42 29 30 34 35 36 43 44 45 49 50 51 52 http://www.teijin.co.jp/csr/ WEB 3 TEIJIN CSR Report 2014
第二期中期経営計画のレビュー ビジョンと第三期中期経営計画 第三期中期経営計画の経営目標 基本方針 第三期中期経営計画における戦略 製品戦略 領域戦略 地域戦略 研究開発戦略 投資戦略 財務戦略と株主還元 医薬品以外の事業の方針 事業基盤の強化 本日のアジェンダ 1
第三期中期経営計画 -2013~2017 年度 - ーイノベーションへの新たな挑戦 - 大日本住友製薬株式会社代表取締役社長多田正世 2013 年 2 月 19 日 第二期中期経営計画のレビュー ビジョンと第三期中期経営計画 第三期中期経営計画の経営目標 基本方針 第三期中期経営計画における戦略 製品戦略 領域戦略 地域戦略 研究開発戦略 投資戦略 財務戦略と株主還元 医薬品以外の事業の方針 事業基盤の強化
LIFULL アニュアルレポート 2017
LIFULL LIFULL ANNUAL REPORT 2017 Contents 2 4 6 12 16 Vision and Strategy 18 LIFULL 20 LIFULL Value Model 22 22 24 26 28 28 30 30 34 CFO&CSO Fact Data 38 40 3 41 42 44 45 2017 4 1 LIFULL ANNUAL REPORT
2 3 4 5 6 7 8 9 10 12 14 17 20 23 26 28 29 30 32 33 34 35 2
2 3 4 5 6 7 8 9 10 12 14 17 20 23 26 28 29 30 32 33 34 35 2 21 3 CO-GROWING HUMAN CONVINNOVATION 4 5 6 ISO14001 PDCA Plan Do Check Action Plan Do Check Action 7 a a a 8 9 10 input \ output \ DATA input
untitled
215 214 12 ENERGIZING THE FUTURE IIRC ver 1. CONTENTS 2 OUR ROAD 8 12 12 CEO 18 CFO 2 2 22 3 32 38 4 4 46 49 54 56 63 CSR Book WEB CSR http://www.showa-shell.co.jp/ csr/index.html 215 1 OUR ROAD 3 3 1985
fix_180824_小林製薬様_統合報告書2018_J_4C.indd
2017 Contents 01 03 04 06 08 10 12 20 23 26 30 31 34 35 36 38 40 11 46 MD&A 48 50 56 57 ESG IIRC 01 Something New / Something Different SimpleClearSpeed 02 2017 2017100 35 03 1886 1970 1975 1894 10 1994
Quality of Life Human Chemistry, Human Solutions Quality of Life Quality of Life HumanChemistry HumanSolutions ChemistrySol
2006 CSR 2005 7519936Quality of Life 1020034 Human Chemistry, Human Solutions Quality of Life 1 2 3 Quality of Life 1 2 3 HumanChemistry HumanSolutions ChemistrySolutions21 Chemistry 1 TEIJIN CSR Report
untitled
Report 214 21412 FEATURE-1 1 HORIBA FPD HORIBA Report 214 2 FEATURE-1 HORIBACSR HORIBA HORIBA 1945 195 1955 196 1965 197 1975 1945 1953 197 1974 1971 195 ph 1964 M EXA 19771978 3 1,53 172 198 1985 199
ニコンレポート2016
NIKON REPORT 216 216 216 3 1 2171 19171 216 3Next 1 - Transform to Grow 6 216 2171215 1 http://www.nikon.co.jp/profile/museum/ ABOUT NIKON 2 4 6 BUSINESS STRATEGY 8 9 14 16 BUSINESS PERFORMANCE 18 22 216
Quality of Life Human Chemistry, Human Solutions Quality of Life Quality of Life HumanChemistry HumanSolutions CSRCSR 1 2 C
2007 CSR 2006 7519936Quality of Life 1020034 Human Chemistry, Human Solutions Quality of Life 1 2 3 Quality of Life 1 2 3 HumanChemistry HumanSolutions CSRCSR 1 2 CSR 3 CSR 4 5 6 7 CSR ChemistrySolutions21
9BBH3A8_P0000
02 Yamaha CSR Report 2007 03 Yamaha CSR Report 2007 04 Yamaha CSR Report 2007 Yamaha CSR Report 2007 05 06 Yamaha CSR Report 2007 Yamaha CSR Report 2007 07 08 Yamaha CSR Report 2007 09 Yamaha CSR Report
* Contents 1 2 CEO 4 CEO 5 : Reaching Out Globally 9 13 120 14 16 19 20 24 25 25 26 28 30 31 61 62 63 3 31 IMSJPM MIDAS 2006.1-2010.3
2010 for the Future Reaching Out 2010 2010 3 * Contents 1 2 CEO 4 CEO 5 : Reaching Out Globally 9 13 120 14 16 19 20 24 25 25 26 28 30 31 61 62 63 3 31 IMSJPM MIDAS 2006.1-2010.3 3 31 2010 2009 2010/2009
Contents LINK TO GOOD LIVING 1
5938 216 3 215 4 1216 3 31 Contents... 2... 3... 7... 9... 11... 13... 14... 18... 19... 21... 22... LINK TO GOOD LIVING 1 LIXILCEO 5 3 IoT 6 3 INAX LIXIL CEO 2 196 6 1983 2 MonotaRO MonotaRO11 21 MonotaRO
2009 1. 2. 3. 4. 5. 2 2009 CONTENTS 4 6 8 TOPIC 01 10 TOPIC 02 11 TOPIC 03 12 TOPIC 04 14 TOPIC 05 15 TOPIC 06 15 TOPIC 07 16 18 18 19 20 21 22 22 22 23 24 25 26 27 27 27 28 29 30 TOPIC 08 16 TOPIC 09
2 1,384,000 2,000,000 1,296,211 1,793,925 38,000 54,500 27,804 43,187 41,000 60,000 31,776 49,017 8,781 18,663 25,000 35,300 3 4 5 6 1,296,211 1,793,925 27,804 43,187 1,275,648 1,753,306 29,387 43,025
平成20年度内部評価実施結果報告書《本編》
10 11 12 13 14 15 16 17 Plan Do Check Action 1 2 3 4 146 13 20 43 44 45 62 104 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47
untitled
1 1 2 3 2 1 ( 0) 2000 00 3 4 Check Action Do Plan 5 6 14001 5000 5000 1000 1000 7 8 9 10 2004 0.1 0.1 0.0 0.0 0.0 15.3 483.5 0.4 11 12 13 14 http://kankyou.pref.shizuoka.jp/seikan/seikanindex.htm 15 16
-2-
-1- -2- -3- -4- -5- -6- -7- -8- 10-9- -10-1 2 -11-1 1-12- -13- -14- Plan Do Check Action Check Action 1 -15- -16- -17- -18- -19- -20- -21- -22- 10 2 9 3 9 2 1 10 2 9 3 6 4 1 6 6 10 2 10 2 11 1 8 1 8 4
SMBC Group Report 2018 CEO CEO SMBC Group Report 2018 1 SMBC 4 SMBC 6 7 ESG 10 SMBC 12 CEO 20 22 CFO 27 28 30 32 34 36 38 40 42 SMBC SMBC Group Report 2018 IIRC 2013 12 SMBC Group Report 2018 CSR 2017
１章
... 1... 1... 1... 2... 2... 3... 3... 6... 10... 14... 18... 19... 20... 23... 29... 29... 33... 40... 47... 48... 48... 54... 54... 59... 61 ... 63... 65... 65... 66... 66... 69... 71... 107 1 2 3 //
2
2005 4 2006 4 20 1 2 2005 1,73647.5% 82136.5% 79832.5%47028.9% 2005 1 12 2,80854.8% * 684 75.7% * 2005 Yahoo! 2006 3 16,3231 8,172100.3% Yahoo! 35851.7% Yahoo! Yahoo! ID 2006 3615 ID 21.2% Yahoo! 605 25.7%
page 50 page 52 52 54 55 page 56 page 58 page 62 page 64 CSR 64 CSR 65 67 page 68 Annual Report 2012 RISING ABOVE ADVERSITY 49 2012 6 23 1943 1953 1967 4 1995 4 1996 6 1998 6 2000 6 2003 6 2004 6 2010
アニュアルレポート 2013
050 CSR 2013 6 21 Director and President, SoftBank Holdings Inc. 1981 9 1983 4 1986 2 1996 1 1996 7 2001 6 BB 2004 2 CEO 2004 7 2006 4 CEO 2006 10 CEO 2007 6 CEO 1977 2 1984 10 1988 2 1993 4 1999 9 BB
01 DAITO GROUP CSR Report 2014
DAITO GROUP CSR Report 2014 01 DAITO GROUP CSR Report 2014 DAITO GROUP CSR Report 2014 02 DAITO GROUP CSR Report 2014 03 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 DAITO GROUP CSR Report 2014
CONTENTS
Annual Report 2017 CONTENTS Santen Pharmaceutical Co., Ltd. Annual Report 2017 1 Value Creation 2 Santen Pharmaceutical Co., Ltd. Annual Report 2017 Santen Pharmaceutical Co., Ltd. Annual Report 2017 3
AVA卵巣癌適正使用改訂 indd
Q&A P.58 CONTENTS 2 4 5 5 6 1. 6 2. 10 3. 12 4. 14 5. 15 6. 17 7. 19 8. 20 9. 22 10. 23 11. 24 12. 25 13. 26 14. 27 28 28 28 31 32 32 38 1 38 2 39 40 41 44 44 48 50 58 74 74 76 78 80 81 4 5 6 7 Q&A P.66
...a.T.X 04_PDF.p
2004 Sustainable Focus DAAM P19 P32 P42 P19 P41 P18 P16-17 P22 P23 4 21 KYOWA BIO-INNOVATOR 1. 2. 3. 4. 5. 6. 7. 8. 9. Kyowa Hakko Group s Sustainability Universe OUT CO2 SOx NOx IN OUT 2 MR IN OUT CONTENTS
ヤマトグループ CSR報告書2007
CONTENTS 1 2 3 5 7 HIGHLIGHT 11 13 14 15 HIGHLIGHT 19 21 22 23 24 25 29 31 HIGHLIGHT 33 35 41 45 48 49 51 53 54 1 2 3 e- BIZ- BIZ- e - 4 CSR 5 3 CS R 6 5 4 3 2 1 10 9 8 7 6 CSR 2006CSR 7 CSR CSR CS R 8
29 29 12 31 2022 28 60 28 1011 29 29 29 30 31 12 12 29 30 30 30 31 26 4 27 44 27 47 3,214 28 49 3,275 29 41 3,292 30 30 2829 29 28 10 30 89.0 87.8 28 18 28 18 1037 1011 026 1037 1019 018 1212 1123 049
三越伊勢丹ホールディングスレポート 2018 CSR
三越伊勢丹ホールディングスレポート 2018 CSR Contents 02 03 07 13 23 27 31 39 43 51 53 CSR 2019 3 31 01 ISETAN MITSUKOSHI HOLDINGS 私たちの考え方 INTEGRATED REPORT 2018 02 三越伊勢丹グループについて 数字で見る三越伊勢丹グループ 2 6 63 1 18 4 2 4 24100 34
CONTENTS
57 20 4 121 3 31 CONTENTS 01 02 1 07 09 11 15 16 17 21 6 25 6 J-POWER 57 1 J-POWER 1 J-POWER 01 J-POWER 57 J-POWER 57 02 3 20 5 1. 2. 3. P.07 08.09 10 20 2 20J-POWER 5 24 22550500 24600 20 9.9% 5 5 5 2
untitled
216 215 12 ENERGIZING THE FUTURE CIS 1% CONTENTS 2 4 CEO 12 2 2 : TO THE NEXT GROWTH STAGE 22 28 LPG 36 36 38 43 46 47 IIRC ver 1. CSR Book WEB CSR 216 6 http://www.showa-shell.co.jp/csr/index.html 216
untitled
CONTENTS 002 004 006 27 008 27 011 PART 1 012 27 013 015 017 019 020 MCEV 023 027 PART 2 028 030 034 036 LiPSS 038 040 042 043 046 049 052 057 PART 3 058 ERM Enterprise Risk Management 060 061 064 067
日立 統合報告書 2017 (2017年3月期)
MANAGEMENT & 2017 6 01 1972 Bharat Forge Limited 1983 1994 1997 2016 02 1991 Alcan Inc. 1996 1998 2002 CEO 2007 Anglo American plc. CEO 2013 4 2013 03 2002 2010 2013 2014 2015 2017 04 1993 Emerson Electric
A Message From President 2
A Message From President 2 Top Information 3 Top Information 4 A View Point 5 Annual Report 2 Financial Highlight 7, 5, 12, 6, 5, 4, 3, 2, 1, 4, 3, 2, 1, 1, 8, 6, 4, 2, 6 5, 2, 8 4, 1,5 6 3, 2, 1, 1, 5
「消える」金融、｢創る｣金融－2010年のリテール金融
2010 2010 CONTENTS 1 2 3 4 18 20066 1 2 19 20 20066 3 1 12 21 2 22 20066 3 4 23 1 1997 1997 1984 1893 1983 1980 2001 1990 1990 24 20066 1 260 26,418 213,597 239,416 1720062 25 2 3 26 20066 3 5 27 4 4 44
MSD Human Resources Global Compliance Organization Office of Ethics Global Safety and the EnvironmentGlobal Compliance Organization Office of Ethics O
Be well III MSD Human Resources Global Compliance Organization Office of Ethics Global Safety and the EnvironmentGlobal Compliance Organization Office of Ethics Office of Ethics Office of Ethics OFFICE
2
1 2 (10 ) 900 800 200 20% 7732 ) 700 600 500 400 300 55.9 26.2 81.5 20 29 30.1 64.7 66.1 31.4 88.4 19.4 31.1 32 67.7 73.5 36.3 95.6 20.5 32.1 33.2 63.7 101.9 89.1 49.1 42.8 129.7 112.9 22.3 23.4 41.3 36.8
18725 136 2008 3 4 6 8 10 16 18 24 40 41 6 42 43 54 59 75 76 77 CSR 30 34 38 200620072008 3 4.27,235 26.9635 1.68.8 ROE2.69.2 1234.0 1 2006 2007 2008 2008/2007 2008 670,957 694,594 723,485 +4.2% $7,220,409
1 4 2 3 4 2 3 OJT/offJT () 2 第11期 年次報告書
Top message 1961 1986 1986 2000 1 Nippon Commercial Development REPORT Nippon Commercial Development REPORT 2 Top message 20,000 15,492 15,000 11,201 10,000 7,993 1,200 1,200 1,000 1,000 800 800 600 600
アニュアルレポート 2014
SoftBank Corp. ANNUAL REPORT 2014 053 The Fast Read CSR SoftBank Corp. ANNUAL REPORT 2014 054 The Fast Read CSR 2014 6 20 1981 9 1983 4 1986 2 1996 1 1996 7 2001 6 BB 2004 2 CEO 2004 7 2006 4 CEO 2006
参考資料
CO2 ( http://www.mext.go.jp/a_menu/shisetu/ecoschool/detail/1291993.htm ACTION CHECK PLAN DO 19 60 n=2,138 202 n=2,138 202 40 3020 20 17 7420 4320 25 30 55 25 C A B C 25 50 75 D 13 1,140 18 872 1990 210
株式会社フジテレビジョン
66 184118930 Fuji TV Report Cover Contents 2 Top Message 3 Top Interview 6 Corporate Business Plan 7 Fuji TV Outline 10 Special Report 11 Consolidated Financial Statements 13 Non-Consolidated Financial
SBSGroup_CSR_h01-h04_0820CS5.ai
CSR Report 2015 SBS GROUP CSR REPORT 2015 1 CSR Report 2015 Contents 3 11 19 22 5 7 15 17 21 2 SBS GROUP CSR REPORT 2015 3 4 SBS GROUP CSR REPORT 2015 5 6 SBS GROUP CSR REPORT 2015 7 8 SBS GROUP CSR REPORT
e DACWeb 11 Google Keyword Search $2.5Billion2003 IABInteractive Advertising Bureau Google Nasdaq 2004/7 520 2004/10 490 2004/10 Omnicom Group 150 200
10 10 e DACWeb 11 Google Keyword Search $2.5Billion2003 IABInteractive Advertising Bureau Google Nasdaq 2004/7 520 2004/10 490 2004/10 Omnicom Group 150 2004/10 3.5 12 13 11 DAGMAR 14 1520% 12 15 Media
% 1,310 1, , % % , , , C
1 2 3 311 % 1,310 1,409 102.0 107.5 1,455 103.3 2015 2016 2017 % 63 64 51 % 115 111 8.8 7.9 94 6.5 2015 2016 2017 1 1 1 1 1,117.23 1,081.49 1,019.68 Contents 01 03 07 09 15 2016 16 CSR 17 21 23 24 25 26
磐田市水道事業ビジョン
20162025 I w a t a C i t y W a t e r w o r k s V i s i o n C o n t e n t s 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2049 (H21) (H22) (H23) (H24) (H25) (H26)
avex-Pages.indd
Backstage Value Multiplier 21 9.4.1-1.3.31 Giving Life to a Blossoming Crescendo avex group 1 : 25 26 27 28 29 1 ORANGE RANGE EXILE 2 EXILE 3 Mr. Children B'z 4 SMAP EXILE B'z 5 KAT-TUN 6 EXILE KAT-TUN
The Chain of Choice FC2008 FC Q&A Being the Chain of Choice for Franchise Owners FC FC Q A CSR
Our Overriding Goal 2008 2008 2 01 02 03 04 12 The Chain of Choice FC2008 FC Q&A Being the Chain of Choice for Franchise Owners FC 18 21 22 24 26 27 71 72 73 2008FC Q A CSR The Chain of Choice FC CVS FC
5 10 10-1 - 5 20-2 - - 3 - - 4 - 22 6 30 10 12 22 7 8 1 30 4 30 1 22 7 14 10 12 20 22 7 21 1 30 3 30-5 - - 6 - - 7 - 11 9 9 14 10 9 15 7 9 10 NPO - 8 - - 15 - - 16 - - 17 - - 19 - - 20 - - 21 - - 22
奄美地域の自然資源の保全・活用に関する基本的な考え方(案)
1 15 5 15 16 19 20 2 3 10 25,000 30,000 6 8 710 11 16 4 1213 1415 17 17 28 17 126,483 30 5 70,462 8,572 27,167 14,551 5,731 29 18 560 10 1,032 1 6 1,300 47 28 4 19 1 8 23 17 100 7 15 8 NPO IT 1979 9 NPO
TOP MESSAGE 世の中に驚きと感動を与える新たなオンキヨーへ 常に新しい価値提案を行い 驚きと感動で未来を動かそう GROUP 株主の皆様におかれましては ますますご清栄のこととお慶び申し上げます この度 2010 年 12 月にオンキヨーグループは 持株会社体制へ移行し
ビジネスレポート 証券コード 6628 平成 23 年 3 月期第 2 四半期 ( 累計 ) 平成 22 年 4 月 1 日 平成 22 年 9 月 30 日 TOP MESSAGE 世の中に驚きと感動を与える新たなオンキヨーへ 常に新しい価値提案を行い 驚きと感動で未来を動かそう GROUP 2010 12 1 株主の皆様におかれましては ますますご清栄のこととお慶び申し上げます この度 2010
20 3 2
2007 2 2007 10 24 1 20 3 2 20072 3 20072 4 20072 5 2007 DD JWord TV 6 2007 2007 4-9 2006 4-9 1,177 1,004 17 % 72 41 72 % 1,105 962 15 % 597 490 22 % 578 477 21 % 292 268 9 % EPS 483 443 9 % 6,047 6,045
untitled
1 BCP(Business Continuity Plan) 1 BCP 2 BCP 6 9 10 BCP 10 11 BCP 12 BCP 15 BCP 16 BCP 17 17 BCP 18 BCP 19 22 24 25 26 28 28 33 37 BCP 41 BCP BCP BCP BCP BCP BCP(Business Continuity Plan) 1 2 BCPBusiness
untitled
ANNUAL REPORT 28 28 3 28 3 1. 1, 35.4% 2. 11.7% 8.1% 3. 17.9% 29.3% 4. Contents 2 4 6 1 12 14 7 1 16 1 18 2 28 3 2 21 22 23 & 24 CSR 26 28 29 57 58 59 Annual Report 28 1 2728 3 28 27 28 336,864 31,88 $
90 27 1 29 ( ) 27 4 26 ( ) 27 4 29 ( ) 4 27 3 30 ( ) 1 30 4 27 4 8 ( ) 16 ( ) 9 P2 3 301 27 4 14 ( ) 15 ( ) 9 5 27 4 21 ( ) 4 27 4 21 ( ) 8 30 5 27 4 23 ( ) 5 10 11 12 13 4 3 4 14 27 4 23 ( 27 4 25 ( )
Lixil_H1-4_13_PDF.indd
2012 Our Business, Our CSR C O N T E N T S 08 Feature 1 04 Feature 2 14 02 06 Feature 3 20 g 24 Report 1 Report 4 29 33 Report 7 26 Report 2 30 Report 5 Report 8 34 Report 3 28 Report 6 32 35 03 04 Management
アニュアルレポート2014
86 ITOCHU Corporation Annual Report 2014 Governance 13 2 5 3 1 HMC Headquarters Management Committee 1997 1999 2007 1 2011 2014 7 113 2 2011 62 HMC Headquarters Management Committee HMC 35 ITOCHU Corporation
正義感を持って世の中の 不 を解消しよう もっと何かできるはず
217 231-8528 89-1 csr tel 45-226-1518 FaX 45-226-123 e-mail csr_promote@fancl.co.jp 正義感を持って世の中の 不 を解消しよう もっと何かできるはず 198 199 2 198 1985 1992 1996 2 215 1981 1993 1996 24 2 1 2 215 217 4 6 217 7 1982 1989
CEO ,19 6, , ,597 12,229 16,389 18, ,48 CIS 3,326 1,65 3, ,358 2, 17,19 15, 14,3
Environmental & Social Report 26 19211513 17-8414 36 CEO 678 2631 25 17,19 6,273 157 263 5,979 263 34,597 12,229 16,389 18,28 263 7,48 CIS 3,326 1,65 3,214 791 1,358 2, 17,19 15, 14,347 1,963 1,898 11,964
ニコンレポート2017
NIKON REPORT 217 217 217 3 Unlock the future with the power of light 217 7 251 1 1 1 217216 11 Unlock the future with the power of light 2 NIKON REPORT 217 BUSINESS STRATEGY 2 3 8 CFO 1 1 12 FAQ 13 TOPICS
untitled
BCP 1 23 4 1 p.1 1.1 p.1 1.2 p.1 1.3 p.2 1.4 p.3 1.5 p.5 1.6 p.5 1.6.1 1.6.2 1.6.3 2 p.8 2.1 p.8 2.2 p.9 2.3 p.9 2.4 p.9 2.4.1 2.4.2 2.4.3 2.5 p.11 2.5.1 2.5.2 2.6 p.12 2.6.1 2.6.2 3 p.15 3.1 p.15 3.2
thermometer AnnuAl RepoRt 2011 Terumo CorporaTion
2011 2011 3 1921 10 thermometer 1921 1853 1931 AnnuAl RepoRt 2011 Terumo CorporaTion 2011 5 01 Introduction MRS. GIeSeKe 1994 DuraHeart DuraHeartDuraHeart 5 DuraHeart DuraHeart DuraHeart duraheart 2007
80% No.1 3... 1... 2... 5... 5... 9... 13... 14... 22... 22... 23... 24... 26... 27... 53... 54
2005 2005 3 Looking ahead 80% No.1 3... 1... 2... 5... 5... 9... 13... 14... 22... 22... 23... 24... 26... 27... 53... 54 20052004 3 2005 3 2004 3 2005/2004 2005 3... 92,696 89,858 3.2% $ 863,175... 18,982
環境報告書2003
1 2 2003 20057 2003 2003420043 2004 web http://www.maruha.co.jp/index.html 20044 3 2004 7 ISO 4 1998112 199891 2001119 2 5 6 LCA 7 3 INPUT OUTPUT INPUT OUTPUT NOxSOx INPUT OUTPUT 8 2003 10 2 31 31 200441
untitled
CONTENTS 1 2 4 6 8 10 11 12 14 15 16 17 18 19 20 21 22 23 24 27 28 29 30 31 32 33 Top Message 2 Daifuku Co., Ltd. CSR Report 2010 Daifuku Co., Ltd. CSR Report 2010 3 4 Daifuku Co., Ltd. CSR Report 2010
untitled
27.4.1 s 28.3.31 31 8515 Vol.24 June 28 Top Message 283 1 16 4 17 5 Topics 18 CSR 7 19 1 2 12 21 21 4,574,99 321,63274 1 3 Top Message 2 4,112 33 317 2825 7 64%5% ROA1.5% 5, 1, 15, 2, 25, 3, 25,225 25/3
2006 2 2006 10 23 1 19 3 200546 20061 2 2006 2 5123.9% 24.5% 2504.3% 31.5%247 7.9% 33.5% 2120.3% 35.9% Yahoo! Yahoo! 22,304 2,62813.4%12,747133.4% Yahoo! Yahoo! 1146.3% 42.0% 3 2006 2 Yahoo! CM 3% 5% Yahoo!Yahoo!
2
23 12 28 23 15 ------ ------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------
maiji2007_cover_j_0907
27 CORPORATE PHILOSOPHY THE MEIJI DAIRIES GROUP CONTRIBUTES TO A HEALTHY AND HAPPY DAILY LIFE FOR OUR CUSTOMERS BY OFFERING NEW LEVELS OF VALUE IN FOOD. CONTENTS 2 4 6 1 1 11 12 13 14 16 18 19 2 22 23
AGENDA
AGENDA IPA JPCERT ) A B C D F,,,,, H14.2 IPA/JNSA (CSR: Corporate Social Responsibility) ISMS ISO17799 BS7799 JISQ15001 ISO15408 Step1 Step2 ISMS Step3 Step4 Step5 Step6 Act Plan Check Do Management
untitled
C O N T E N T S 02 06 07 08 09 11 12 14 16 17 18 2 0 0 8 W I N T E R 105 No. 20082 SG2009 President & CEO Teruo Asada 10312008220089 20082 Top Message 120082 2 1,064 1,392 46%5241,657 1,000 5 32%261 45